Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial.

< BACK TO ARCHIVE


2023 Jan 31


J Infect Dis


http://www.ncbi.nlm.nih.gov/pubmed/36722044?dopt=Abstract

Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial.

Authors

Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial.
Baksh S, Heath SL, Fukuta Y, Shade D, Meisenberg B, Bloch EM, Tobian AAR, Spivak ES, Patel B, Gerber J, Raval JS, Forthal D, Paxton J, Mosnaim G, Anjan S, Blair J, Cachay E, Currier J, Das P, Huaman M, et al.
J Infect Dis. 2023 Jan 31.
PMID: 36722044.

Abstract

COVID-19 convalescent plasma (CCP) reduces hospitalizations among outpatients treated early after symptom onset. It is unknown if CCP reduces time to symptom resolution among outpatients.
Read This Paper